TY  - GEN
AU  - Mayerhoefer,Marius E
AU  - Karanikas,Georgios
AU  - Kletter,Kurt
AU  - Kiesewetter,Barbara
AU  - Weber,Michael
AU  - Rausch,Ivo
AU  - Pones,Matthias
AU  - Simonitsch-Klupp,Ingrid
AU  - Müllauer,Leonhard
AU  - Dolak,Werner
AU  - Lukas,Julius
AU  - Raderer,Markus
TI  - Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients
SN  - 1536-0229
PY  - 2017///0111
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Breast Neoplasms
KW  - diagnostic imaging
KW  - Diffusion Magnetic Resonance Imaging
KW  - Eye Neoplasms
KW  - Female
KW  - Fluorodeoxyglucose F18
KW  - Humans
KW  - Image Processing, Computer-Assisted
KW  - Immunotherapy
KW  - Lacrimal Apparatus Diseases
KW  - Lung Neoplasms
KW  - Lymph Nodes
KW  - Lymphoma, B-Cell, Marginal Zone
KW  - Male
KW  - Middle Aged
KW  - Multidetector Computed Tomography
KW  - Positron Emission Tomography Computed Tomography
KW  - Positron-Emission Tomography
KW  - Prognosis
KW  - Prospective Studies
KW  - Radiopharmaceuticals
KW  - Remission Induction
KW  - Rituximab
KW  - Soft Tissue Neoplasms
KW  - Splenic Neoplasms
KW  - Stomach Neoplasms
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1097/RLU.0000000000001395
ER  -